Welcome to Amgen Care

Welcome to Amgen Care

Support for patients

This site is designed to provide information to patients who have been prescribed an Amgen® medicine. Should you have any concerns or questions regarding your treatment, please speak to your doctor or nurse.

Please select one of the options below:

I am, or I care for, an AMGEVITA®▼ (adalimumab) patient.
Enter site
I am, or I care for, a Repatha® (evolocumab) patient.
Enter site
I am, or I care for, a Prolia® (denosumab) patient.
Enter site
I am, or I care for, an Aranesp® (darbepoetin alfa) nephrology patient
Enter site
I am, or I care for, a Vectibix® (panitumumab) patient
Enter site
I am, or I care for, an Aranesp® (darbepoetin alfa) oncology patient
Enter site
I am, or I care for, a Kyprolis®▼ (carfilzomib) patient
Enter site
I am, or I care for, a Neulasta® (pegfilgrastim) patient
Enter site
I am, or I care for, an XGEVA® (denosumab) patient
Enter site
I am, or I care for, a Nplate® (romiplostim) patient
Enter site
I am, or I care for, a Neupogen® (filgrastim) patient
Enter site
I am, or I care for, a Blincyto®▼ (blinatumomab) patient
Enter site
I am, or I care for, a Mimpara® (cinacalcet) patient
Enter site
I am, or I care for, an Otezla® (apremilast) patient
Enter site
I am a member of the general public and have not been prescribed any of these Amgen® medicines.
Enter site

Safety information

▼This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the patient leaflet. Side effects can be reported directly to the Health Products Regulatory Authority (HPRA) using the available methods via www.hpra.ie. Side effects should also be reported to Amgen Limited on +44 (0) 1223 436441 or Freephone 1800 535 160. By reporting side effects you can help provide more information on the safety of this medicine.

This site is intended for patients in Ireland who are being treated with an Amgen® product and for Irish Healthcare Professionals (HCPs).

I am a member of the public
IE-CBU-0820-00002 August 2020